Diabetes mellitus Posts - Page 8 of 108 on Medivizor
Navigation Menu

Diabetes mellitus Posts on Medivizor

Evaluating thinking and reasoning performance in adults with type 1 diabetes over the long-term

Evaluating thinking and reasoning performance in adults with type 1 diabetes over the long-term

Posted by on Aug 1, 2021 in Diabetes mellitus | 0 comments

In a nutshell This long-term study looked at mental sharpness and coordination as adults age with type 1 diabetes (T1D). It found that blood sugar control over the previous 30 years influences later coordination and memory. Some background People with type 1 diabetes (T1D) are now living much longer and fuller lives, due to improved treatment. Because...

Read More

Evaluating thinking and reasoning performance in adults with type 1 diabetes over the long-term

Evaluating thinking and reasoning performance in adults with type 1 diabetes over the long-term

Posted by on Aug 1, 2021 in Diabetes mellitus | 0 comments

In a nutshell This long-term study looked at mental sharpness and coordination as adults age with type 1 diabetes (T1D). It found that blood sugar control over the previous 30 years influences later coordination and memory. Some background People with type 1 diabetes (T1D) are now living much longer and fuller lives, due to improved treatment. Because...

Read More

Does real-time glucose monitoring improve diabetic control in patients with type 1 diabetes?

Does real-time glucose monitoring improve diabetic control in patients with type 1 diabetes?

Posted by on Jul 31, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared two methods of continuous glucose monitoring (CGM) for patients with type 1 diabetes (T1D). It found that compared to intermittent monitoring, real-time monitoring led to better glucose control and reduced risk of severe hypoglycemia. Some background Treatment of type 1 diabetes (T1D) has improved in recent years...

Read More

Comparing second-line therapy options combined with metformin for patients with type 2 diabetes.

Comparing second-line therapy options combined with metformin for patients with type 2 diabetes.

Posted by on Jul 25, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study explored the effects of different second-line therapies combined with metformin (Glucophage) in patients with type 2 diabetes (T2D). The data showed that metformin combinations with a sulfonylurea (SU) had the lowest weight loss, the smallest effect of lowering blood glucose, and an overall, reduced health...

Read More

Can eye drops with citicoline and vitamin B12 help to prevent worsening of diabetic eye disease?

Can eye drops with citicoline and vitamin B12 help to prevent worsening of diabetic eye disease?

Posted by on Jul 25, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at the use of citicoline and vitamin B12 eye drops (OMK2) to prevent diabetic retinopathy (DR; eye disease) in patients with type 1 diabetes (T1D). It found that using these drops for 36 months improved eye function tests.  Some background Type 1 diabetes (T1D) is a common cause of blindness through...

Read More

Which heart procedure has better outcomes in patients with diabetes and heart disease?

Which heart procedure has better outcomes in patients with diabetes and heart disease?

Posted by on Jul 17, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study compared two heart interventions for people with coronary heart disease and type 2 diabetes (T2D). It found that coronary artery bypass grafting (CABG) led to better long-term outcomes than placing a stent in these patients. Some background Coronary heart disease (CHD) is a condition in which the arteries which supply blood to...

Read More

Evaluating the outcomes of cotadutide treatment for patients with type 2 diabetes

Evaluating the outcomes of cotadutide treatment for patients with type 2 diabetes

Posted by on Jul 11, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study evaluated the outcomes of cotadutide (MEDI0382) treatment in patients with type 2 diabetes (T2D) and obesity. This study concluded that cotadutide treatment improved glycemic (blood sugar) control and weight loss in these patients. Some background T2D is commonly associated with obesity. About 70% of patients with T2D...

Read More

Are all glucagon-like peptide-1 receptor agonists equally safe and effective in patients with type 2 diabetes?

Are all glucagon-like peptide-1 receptor agonists equally safe and effective in patients with type 2 diabetes?

Posted by on Jul 11, 2021 in Diabetes mellitus | 0 comments

In a nutshell This study looked at 8 glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of type 2 diabetes (T2D). They found that all 8 were more effective than placebo and there were no significant differences in safety. Some background GLP-1RA is a type of diabetic medication that works by increasing natural...

Read More